CASQ2 variants in Chinese children with catecholaminergic polymorphic ventricular tachycardia
- PMID: 31482657
- PMCID: PMC6825949
- DOI: 10.1002/mgg3.949
CASQ2 variants in Chinese children with catecholaminergic polymorphic ventricular tachycardia
Abstract
Background: Biallelic variants of the CASQ2 are known to cause the autosomal recessive form of catecholaminergic polymorphic ventricular tachycardia (CPVT), an inherited disease that predisposes young individuals to syncope and sudden cardiac death. To date, only about 24 CASQ2 variants have been reported in association with CPVT pathogenesis; furthermore, studies in Asians, especially in the Chinese population, are relatively rare. The aim of this study was to detect CASQ2 variants in Chinese patients with CPVT.
Methods: We used targeted next-generation sequencing (NGS) to identify CASQ2 variants in Chinese patients with CPVT. A screening process was performed to prioritize rare variants of potential functional significance. Sanger sequencing was conducted to conform the candidate variants and determine the parental origin.
Results: We identified seven different CASQ2 variants, of which three (c.1074_1075delinsC, c.1175_1178delACAG, and c.838+1G>A) have not been previously reported. The variants exhibited autosomal recessive inheritance, and were detected in four unrelated Chinese families with CPVT. They included a nonsense variant c.97C>T (p.R33*) and a missense variant c.748C>T (p.R250C) in Family 1 with three CPVT patients; two heterozygous frameshift variants, c.1074_1075delinsC (p.G359Afs*12) and c.1175_1178delACAG (p.D392Vfs*84), in Family 2 with one CPVT patient; one pathogenic homozygous variant c.98G>A (p.R33Q) of CASQ2 in the CPVT patient of Family 3; and two heterozygous splicing variants, (c.532+1G>A) and (c.838+1G>A), in Family 4 with one CPVT patient.
Conclusion: To our knowledge, this is the first systematic study of Chinese children with CASQ2 variants. Our work further expands the genetic spectrum of CASQ2-associated CPVT.
Keywords: CASQ2 variants; autosomal recessive; catecholaminergic polymorphic ventricular tachycardia; targeted next-generation sequencing.
© 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of CASQ2-Catecholaminergic Polymorphic Ventricular Tachycardia.Circulation. 2020 Sep 8;142(10):932-947. doi: 10.1161/CIRCULATIONAHA.120.045723. Epub 2020 Jul 22. Circulation. 2020. PMID: 32693635 Free PMC article. Clinical Trial.
-
Compound heterozygous CASQ2 mutations and long-term course of catecholaminergic polymorphic ventricular tachycardia.Mol Genet Genomic Med. 2017 Nov;5(6):788-794. doi: 10.1002/mgg3.323. Epub 2017 Aug 22. Mol Genet Genomic Med. 2017. PMID: 29178653 Free PMC article.
-
A novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia.Heart Rhythm. 2016 Aug;13(8):1652-60. doi: 10.1016/j.hrthm.2016.05.004. Epub 2016 May 5. Heart Rhythm. 2016. PMID: 27157848 Free PMC article.
-
Catecholaminergic polymorphic ventricular tachycardia (and seizure) caused by a novel homozygous likely pathogenic variant in CASQ2 gene.Gene. 2024 Feb 15;895:148012. doi: 10.1016/j.gene.2023.148012. Epub 2023 Nov 22. Gene. 2024. PMID: 37995796 Review.
-
Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia.Pediatr Cardiol. 2012 Aug;33(6):959-67. doi: 10.1007/s00246-012-0256-1. Epub 2012 Mar 16. Pediatr Cardiol. 2012. PMID: 22421959 Free PMC article. Review.
Cited by
-
Clinical Characteristics, Genetic Findings and Arrhythmic Outcomes of Patients with Catecholaminergic Polymorphic Ventricular Tachycardia from China: A Systematic Review.Life (Basel). 2022 Jul 22;12(8):1104. doi: 10.3390/life12081104. Life (Basel). 2022. PMID: 35892906 Free PMC article. Review.
-
The function and regulation of calsequestrin-2: implications in calcium-mediated arrhythmias.Biophys Rev. 2022 Jan 7;14(1):329-352. doi: 10.1007/s12551-021-00914-6. eCollection 2022 Feb. Biophys Rev. 2022. PMID: 35340602 Free PMC article. Review.
-
An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of CASQ2-Catecholaminergic Polymorphic Ventricular Tachycardia.Circulation. 2020 Sep 8;142(10):932-947. doi: 10.1161/CIRCULATIONAHA.120.045723. Epub 2020 Jul 22. Circulation. 2020. PMID: 32693635 Free PMC article. Clinical Trial.
-
Clinical Characteristics, Genetic Basis and Healthcare Resource Utilisation and Costs in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia: A Retrospective Cohort Study.Rev Cardiovasc Med. 2022 Aug 5;23(8):276. doi: 10.31083/j.rcm2308276. eCollection 2022 Aug. Rev Cardiovasc Med. 2022. PMID: 39076628 Free PMC article.
-
Identification of Key Biomarkers in Bladder Cancer: Evidence from a Bioinformatics Analysis.Diagnostics (Basel). 2020 Jan 24;10(2):66. doi: 10.3390/diagnostics10020066. Diagnostics (Basel). 2020. PMID: 31991631 Free PMC article.
References
-
- Eckey, K. , Strutz‐Seebohm, N. , Katz, G. , Fuhrmann, G. , Henrion, U. , Pott, L. , … Seebohm, G. (2010). Modulation of human ether a gogo related channels by CASQ2 contributes to etiology of catecholaminergic polymorphic ventricular tachycardia (CPVT). Cellular Physiology and Biochemistry, 26(4–5), 503–512. 10.1159/000322318 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources